NASDAQ:OYST Oyster Point Pharma (OYST) Stock Price, News & Analysis → Central Banks Preparing for US Dollar Collapse? (From Behind the Markets) (Ad) Free OYST Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$11.17▼$11.1750-Day Range$11.08▼$11.2052-Week Range$3.46▼$19.00Volume330 shsAverage Volume212,171 shsMarket Capitalization$299.85 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Oyster Point Pharma alerts: Email Address Ad Crypto 101 MediaMajor Elon Musk Crypto Leak RevealedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. About Oyster Point Pharma Stock (NASDAQ:OYST)Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry eye disease. It is also developing TYRVAYA that is in Phase II clinical trial for the treatment of for neurotrophic keratopathy. The company was incorporated in 2015 and is headquartered in Princeton, New Jersey.Read More Ad DTIWarning: this could blow your mindBuckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…Watch the presentation here OYST Stock News HeadlinesMarch 28, 2024 | msn.comThe 10 Best Oyster Restaurants In AtlantaMarch 28, 2024 | msn.comBroad Street Oyster Co.’s Legendary Lobster Rolls Land at Ghirardelli Square TomorrowMarch 29, 2024 | DTI (Ad)Warning: this could blow your mindBuckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…March 24, 2024 | msn.comWhat’s the Best Substitute for Oyster Sauce? We Have 10 Tasty SwapsMarch 9, 2024 | sports.yahoo.comSophomore Bussiere shines in net for Oyster River/Portsmouth in state championship lossMarch 6, 2024 | yahoo.comAww shucks!!! Oyster recycling program reaches major milestoneMarch 5, 2024 | uk.finance.yahoo.comBiotechnology Licensing Deals Analysis Reveals Key Trends and Major Agreements from 2019-2024February 28, 2024 | uk.finance.yahoo.comQ4 2023 Viatris Inc Earnings CallMarch 29, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.February 22, 2024 | news.yahoo.comOyster River School Board candidate John ColwellFebruary 18, 2024 | thestreet.comOyster Point Pharma Inc.February 16, 2024 | yahoo.comNew restaurant: Grill and oyster bar features burgers, fresh seafood, raw barFebruary 16, 2024 | sports.yahoo.comThursday Seacoast roundup: Oyster River/Portsmouth's Metcalf nets two in girls hockey winFebruary 9, 2024 | yahoo.comWhat Is Oyster Pie?February 8, 2024 | bizjournals.comKilroy's mega project at Oyster Point is facing a 6 month delay. Here's whyJanuary 25, 2024 | msn.comOyster Sales Plummet at LA Restaurants Amid Unclear Guidance From Health OfficialsJanuary 23, 2024 | news.yahoo.comOyster roast helps further land trust missionJanuary 21, 2024 | msn.comPopular Dayton restaurant hosting 8th annual Oyster FestJanuary 20, 2024 | msn.comAvoid All Oysters Imported from Mexico, Health Officials Warn, as Norovirus Cases SpreadJanuary 18, 2024 | yahoo.comRaw oyster illnesses traced to parts of Mexico: Public HealthJanuary 17, 2024 | msn.comRaw Oyster Warning Expanded Across SoCal After Dozens SickenedJanuary 16, 2024 | news.yahoo.comWarning over raw oyster consumption expands to more parts of Southern CaliforniaJanuary 16, 2024 | msn.comAlabama wild oyster harvest declines; predator ‘infestation’ blamedJanuary 13, 2024 | msn.comKing oyster mushrooms: the versatile food lowering bad cholesterol and adding flavor to your mealsJanuary 12, 2024 | thejournalnj.comOyster Point Hotel and Molly Pitcher Inn Host Exclusive Bridal ShowJanuary 12, 2024 | seekingalpha.comFrom Euphoria To Reality: Viatris' Tale Of Market WhirlwindJanuary 10, 2024 | finance.yahoo.comDry Eye Syndrome Market Size Worth USD 10.55 Billion in 2032 | Emergen ResearchSee More Headlines Receive OYST Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Oyster Point Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/04/2021Today3/29/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological products, except diagnostic Sub-IndustryN/A Current SymbolNASDAQ:OYST CUSIPN/A CIK1720725 Webwww.oysterpointrx.com Phone609-382-9032FaxN/AEmployees303Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($6.65) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-100,660,000.00 Net Margins-901.99% Pretax Margin-901.99% Return on Equity-490.33% Return on Assets-108.29% Debt Debt-to-Equity Ratio8.49 Current Ratio3.35 Quick Ratio3.11 Sales & Book Value Annual Sales$24.54 million Price / Sales12.22 Cash FlowN/A Price / Cash FlowN/A Book Value$3.80 per share Price / Book2.94Miscellaneous Outstanding Shares26,844,000Free Float22,039,000Market Cap$299.85 million OptionableNot Optionable Beta1.31 The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesDr. Jeffrey Nau MMS (Age 47)Ph.D., Pres, CEO & Director Comp: $962.85kMr. Daniel Lochner M.B.A. (Age 40)CFO & Chief Bus. Officer Comp: $642kMr. George Donato M.B.A.Sr. VP of CMC & OperationsDr. Eric Carlson Ph.D.Chief Scientific OfficerArty AhmedVP of Investor relationsMr. Barry Rosenfeld J.D.Sr. VP & Gen. CounselMs. Raegan A. McClain CCEPJ.D., L.L.M., Chief Compliance & Privacy OfficerMs. Karen Castillo-PaffVP of Communications & PRMr. Dave BenadonChief HR OfficerMs. Loni Da Silva M.S.Sr. VP of Regulatory AffairsMore ExecutivesKey CompetitorsFennec PharmaceuticalsNASDAQ:FENCAdverum BiotechnologiesNASDAQ:ADVMAura BiosciencesNASDAQ:AURASOPHiA GENETICSNASDAQ:SOPHPoseida TherapeuticsNASDAQ:PSTXView All Competitors OYST Stock Analysis - Frequently Asked Questions How were Oyster Point Pharma's earnings last quarter? Oyster Point Pharma, Inc. (NASDAQ:OYST) issued its quarterly earnings data on Thursday, November, 4th. The company reported ($0.68) earnings per share for the quarter, beating the consensus estimate of ($1.16) by $0.48. The firm had revenue of $17.94 million for the quarter. Oyster Point Pharma had a negative net margin of 901.99% and a negative trailing twelve-month return on equity of 490.33%. During the same period in the previous year, the business posted ($0.63) EPS. What other stocks do shareholders of Oyster Point Pharma own? Based on aggregate information from My MarketBeat watchlists, some companies that other Oyster Point Pharma investors own include OPKO Health (OPK), Pfizer (PFE), Akero Therapeutics (AKRO), Walt Disney (DIS), Energy Transfer (ET), Fulcrum Therapeutics (FULC), Johnson & Johnson (JNJ), Occidental Petroleum (OXY) and vTv Therapeutics (VTVT). When did Oyster Point Pharma IPO? Oyster Point Pharma (OYST) raised $85 million in an IPO on Thursday, October 31st 2019. The company issued 5,000,000 shares at a price of $16.00-$18.00 per share. J.P. Morgan, Cowen and Piper Jaffray served as the underwriters for the IPO. This page (NASDAQ:OYST) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders Alliance“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oyster Point Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.